Becton Dickinson and Co. (NYSE:BDX)‘s stock had its “market perform” rating reaffirmed by Leerink Swann in a report released on Monday. They presently have a $185.00 target price on the stock, up from their previous target price of $180.00. Leerink Swann’s target price would suggest a potential upside of 7.65% from the stock’s previous close.

Several other analysts have also recently commented on the company. Zacks Investment Research cut Becton Dickinson and from a “buy” rating to a “hold” rating in a report on Wednesday, November 16th. Deutsche Bank AG restated a “buy” rating and set a $189.00 target price (down previously from $197.00) on shares of Becton Dickinson and in a report on Friday, November 4th. Argus restated a “buy” rating and set a $185.00 target price on shares of Becton Dickinson and in a report on Friday, October 21st. Citigroup Inc. cut Becton Dickinson and from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $167.00 to $165.00 in a report on Friday, September 23rd. Finally, Cowen and Company restated an “outperform” rating and set a $185.00 target price on shares of Becton Dickinson and in a report on Tuesday, August 16th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $176.11.

Analyst Recommendations for Becton Dickinson and (NYSE:BDX)

Shares of Becton Dickinson and (NYSE:BDX) traded up 0.16% during midday trading on Monday, reaching $172.13. 342,147 shares of the company’s stock traded hands. The firm has a market capitalization of $36.65 billion, a P/E ratio of 38.34 and a beta of 1.04. Becton Dickinson and has a 52-week low of $129.50 and a 52-week high of $181.76. The stock’s 50 day moving average price is $172.67 and its 200 day moving average price is $172.12.

Becton Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, November 3rd. The company reported $2.12 EPS for the quarter, topping the consensus estimate of $2.09 by $0.03. The company had revenue of $3.23 billion for the quarter, compared to analysts’ expectations of $3.22 billion. Becton Dickinson and had a return on equity of 24.44% and a net margin of 7.82%. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.94 earnings per share. On average, equities research analysts anticipate that Becton Dickinson and will post $9.52 EPS for the current fiscal year.

In related news, insider Linda M. Tharby sold 11,704 shares of the stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the completion of the transaction, the insider now directly owns 22,146 shares in the company, valued at $3,925,821.42. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Stephen Sichak sold 10,352 shares of the stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $176.10, for a total value of $1,822,987.20. Following the transaction, the insider now owns 26,892 shares of the company’s stock, valued at $4,735,681.20. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Nelson Van Denburg & Campbell Wealth Management Group LLC purchased a new position in Becton Dickinson and during the third quarter worth about $108,000. Parkside Financial Bank & Trust increased its position in Becton Dickinson and by 0.8% in the third quarter. Parkside Financial Bank & Trust now owns 624 shares of the company’s stock worth $113,000 after buying an additional 5 shares during the last quarter. Point72 Asia Hong Kong Ltd purchased a new position in Becton Dickinson and during the second quarter worth about $119,000. Acrospire Investment Management LLC increased its position in Becton Dickinson and by 458.0% in the second quarter. Acrospire Investment Management LLC now owns 731 shares of the company’s stock worth $124,000 after buying an additional 600 shares during the last quarter. Finally, Assetmark Inc. increased its position in Becton Dickinson and by 33.0% in the third quarter. Assetmark Inc. now owns 741 shares of the company’s stock worth $133,000 after buying an additional 184 shares during the last quarter. Institutional investors and hedge funds own 82.68% of the company’s stock.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.